International Geographic Variation in Event Rates in Trials of Heart Failure With Preserved and Reduced Ejection Fraction
Author(s) -
Søren Lund Kristensen,
Lars Køber,
Pardeep S. Jhund,
Scott D. Solomon,
John Kjekshus,
Robert S. McKelvie,
Michael R. Zile,
Christopher B. Granger,
John Wikstrand,
Michel Komajda,
Peter E. Carson,
Marc A. Pfeffer,
Karl Swedberg,
Hans Wedel,
Salim Yusuf,
John J.V. McMurray
Publication year - 2014
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.114.012284
Subject(s) - ejection fraction , heart failure , medicine , hazard ratio , confidence interval , cardiology , heart failure with preserved ejection fraction , irbesartan , candesartan , demography , blood pressure , angiotensin ii , sociology
International geographic differences in outcomes may exist for clinical trials of heart failure and reduced ejection fraction (HF-REF), but there are few data for those with preserved ejection fraction (HF-PEF).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom